Escitalopram Tablets USP 20 mg — Class III drug recall D-1516-201
Terminated recall by Lupin Limited, reported 2016-09-28, distributed nationwide. Labeling: Incorrect or Missing Lot and/or Expiration Date
| Recall number | D-1516-201 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Limited, Verna, Salcette, Goa, India |
| Recall initiated | 2016-03-24 |
| Classified | 2016-09-21 |
| Reported by FDA | 2016-09-28 |
| Terminated | 2017-03-15 |
| Distributed | Nationwide (US) |
| Reason classes | labeling |
| NDC | 68180-0135, 68180-0135-01, 68180-0136, 68180-0136-01, 68180-0137, 68180-0137-01, 68180-0137-06 |
| Lot numbers | 11/17, G510086 |
Product
Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01
Reason for recall
Labeling: Incorrect or Missing Lot and/or Expiration Date
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1516-201. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.